Launch of new Pre-doctoral Clinical Academic Fellowship
Created on Tuesday, 24 Oct 2017.
The Pre-doctoral Clinical Academic Fellowship (PCAF) scheme will support award holders to split their time equally between clinical service and academic training over a two year period. During this time, Fellows will undertake formal and informal clinical research training, designed around their unique training needs. One of its many benefits is that it will allow protected time for participants to develop an application for PhD funding, with support from a named supervisor and mentor.
The PCAF scheme is anticipated to open for applications in February 2018 and will replace the current ICA Masters in Clinical Research Studentship scheme.
website: HEE-ICA/Pre-doctoral Clinical Academic Fellowships
phone: 0113 346 6268
New guide to the Integrated Clinical Academic Programme
Created on Monday, 02 Oct 2017.
The ICA Programme provides research training awards for registered healthcare professionals (excluding doctors and dentists) who wish to develop clinical academic careers, combining continued clinical practice and clinical development with clinical research and research leadership.
The ICA Programme comprises five schemes, tailored to support aspiring and developing clinical researchers:
- The HEE Internship scheme: A pre-masters clinical research taster
- Pre-doctoral level support: An introduction to clinical research theory and practice
- The HEE/NIHR Clinical Doctoral Research Fellowship (CDRF) scheme enables registered healthcare professionals (excluding doctors and dentists) to obtain a PhD by research whilst also developing their clinical skills.
- The HEE/NIHR Clinical Lectureship (CL) scheme enables registered healthcare professionals (excluding doctors and dentists) who already hold a doctorate to continue research at a postdoctoral level whilst continuing to contribute to clinical practice and developing clinical leadership.
- The HEE/NIHR Senior Clinical Lectureship (SCL) scheme enables registered healthcare professionals (excluding doctors and dentists) with independent clinical research experience to undertake further research in a senior academic position whilst developing as a clinical academic leader.
Read the new guide for up to date information about scope, eligibility, rationale and aims along with other vital bits of information which will make your application process easier.
NIHR RfPB Programme Guidance on Applying for Feasibility Studies
Created on Monday, 18 Sep 2017.
The NIHR Research for Patient Benefit (RfPB) programme issued updated guidance on applying for feasibility studies (July 2017). This guidance is essential reading for anyone considering applying to the RfPB Programme for funding for feasibility or pilot studies. The following is covered within the guidance:
- Definition of feasibility vs pilot studies
- Feasibility and pilot studies: which NIHR programme should I apply to?
- RfPB policy on funding feasibility and pilot studies
- Guidance on applying to RfPB for a feasibility or pilot study, including:
- Outline of the proposed follow on full trial
- Key parameters which the feasibility study intends to clarify or estimate
- Progression criteria for a full trial
HTA 'commissioning brief supporting information’
Created on Tuesday, 12 Sep 2017.
The Heath Technology Assessment (HTA) programme is currently running a pilot, publishing additional documentation for applicants as part of their commissioned calls. The documentation, called commissioning brief supporting information provides a rationale for the call and summarises the existing evidence base as well as relevant work from HTA and wider NIHR (example document)
In additon HTA also publish a list of potential future research topics that are currently in development for commissioned research.
The Health Foundation launches its Behavioural Insights Research Programme
Created on Thursday, 07 Sep 2017.
The Health Foundation is inviting researchers to submit ideas rooted in ‘behavioural insights’ or ‘nudge theory’ that have the potential to increase efficiency and reduce waste within health care services in the UK.
There is £1.8 million available for up to eight multidisciplinary research teams to generate new knowledge of what can motivate people to act in more efficient and less wasteful ways in health care services.
Each project will receive between £150,000 and £350,000 for research completed over two to three years.
The three priority areas of focus for this programme include:
- patient pathways: eg improving patient flow within the system, improving coordination and transfer of care, expediting discharge
- procurement, pharmacy and medicines optimisation: eg minimising cost and waste in procurement and prescribing, improving medication adherence
- care best practice: eg encouraging attendance, uptake of screening and health promotion, reducing unnecessary or ineffective care, better demand management, reducing harms.
The closing date for applications is 12:00, Friday 20 October 2017.
Government's announcement of up to £86 million support to help innovative UK businesses develop medical breakthroughs that can be used across the NHS
Created on Tuesday, 18 Jul 2017.
The package will allow small and medium sized enterprises (SMEs) to develop and test new technologies in the NHS. This could include innovations such as digital technologies to help patients manage their conditions from home instead of a hospital, or to develop new medicines.
Access to this funding will also speed up the time it takes to get new technologies from the lab to patients in the NHS.
The funding is split into 4 packages:
- £39 million of funding to the Academic Health Science Networks (ASHNs), enabling them to assess the benefits of new technologies and support NHS uptake of those that deliver real benefits to patients according to the local need
- £35 million Digital Health Technology Catalyst for innovators – this will match-fund the development of digital technologies for use by patients and the NHS
- up to £6 million over the next 3 years to help SMEs with innovative medicines and devices get the evidence they need by testing in the real world, building on existing opportunities such as the Early Access to Medicine Scheme (EAMS)
- £6 million Pathway Transformation Fund, which will help NHS organisations integrate new technologies into everyday practices - this will help overcome more practical obstacles such as training staff on how to use new equipment
Changes to the fellowship form (Introduction of Stage 1 & Stage 2)
Created on Wednesday, 05 Jul 2017.
From this month, (nearly) all fellowship applications will follow a two stage process. This new form will be an adapted version of the NIHR Standard Application Form. Provisionally, the two stages have been divided like this:
- Application summary
- CV (this will be extended from previous years)
- Research background
- Plain English summary and scientific summary
- Detailed research plan
- Training and development plan (this is likely to be extended)
- Detailed budget
- Management and governance
Doctoral awards will be invited to submit a stage 2 application after a shortlisting meeting. Post-doctoral awards will be invited to submit a stage 2 after peer review. Feedback won’t be provided between stages and it won’t be possible to revise the research plan between stages.
Charities' Funding Contributes to UK Medical Research Excellence
Created on Tuesday, 20 Jun 2017.
New figures reveal that AMRC members funded over £1.6 billion of medical research across the UK in 2016, the biggest proportion of public funding, compared to £1.04 billion from the National Institute for Health Research, and £0.93 billion from the Medical Research Council.
New Director announced for Research for Patient Benefit Programme
Created on Monday, 15 May 2017.
The new NIHR Research for Patient Benefit (RfPB) Programme Director is Professor Sue Ziebland from the University of Oxford.
Sue Ziebland is Professor of Medical Sociology and Director of the Health Experiences Research Group (HERG) in the Nuffield Department of Primary Care Health Sciences, University of Oxford. She is also a Senior Research Fellow at Green Templeton College, Oxford, and has been an NIHR Senior Investigator since 2013.
Professor Ziebland is one of the founding members of the team that collects and analyses patient narratives for the public-facing website healthtalk.org. Her research interests include how patient narratives can stimulate service improvements and better clinical training; and how the internet is changing healthcare and relationships with health professionals. Her international work includes a comparative study of help-seeking and health system response in Sweden, Denmark and England.
Research for Patient Benefit (RfPB) Tier 3 Funding review published
Created on Tuesday, 02 May 2017.
In competition 26 RfPB introduced a high risk funding tiers (Tier 3), this report identifies what has been currently funded via tier 3. Tier 3 funds projects that are higher risk and further away from patient benefit, the report additionally looks at the pathways the studies take to achieve patient benefit.
- Tier 1 (up to £350k) for research that has a clear and close trajectory to patient benefit, such as a definitive trial.
- Tier 2 (up to £250k) for research proposals which are feasibility studies.
- Tier 3 (up to £150k) for research which is on a pathway to patient benefit yet further from it
To date 21 projects have been funded under tier 3 accounting for 22% of all RfPB funded projects.
The funded projects fall into the following research types:
- 3 systematic reviews
- 7 developing and refining interventions
- 1 meta-analysis
- 1 realist synthesis
- 1 economic evaluation
- 6 secondary data analysis (including developing predictive models and needs assessments)
- 2 diagnostic accuracy studies
Covering four types of research topics and designs:
- Therapeutic – concerned with developing and evaluating interventions to improve patient benefit
- Diagnostic – concerned with ensuring patients are appropriately classified to receive the above intervention
- Needs assessment – concerned with assessing the needs (usually of interventions) in a particular patient population
- Evidence synthesis.